PT  - JOURNAL ARTICLE
AU  - Chee Hoou Loh
AU  - Geoffrey Herkes
TI  - Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab
AID  - 10.1136/bcr-2018-229128
DP  - 2019 May 01
TA  - BMJ Case Reports
PG  - e229128
VI  - 12
IP  - 5
4099  - http://casereports.bmj.com/content/12/5/e229128.short
4100  - http://casereports.bmj.com/content/12/5/e229128.full
SO  - BMJ Case Reports2019 May 01; 12
AB  - We report the experience of reversing dabigatran prior to administering systemic thrombolysis for acute ischaemic cerebellar stroke, which was well tolerated with no haemorrhagic complications after thrombolysis. Given the increasingly common use of dabigatran for atrial fibrillation, the use of idarucizumab to reverse of dabigatran is a novel treatment that should be considered as an important adjunct to facilitate thrombolysis for ischaemic strokes and minimise haemorrhagic complications.